Company Filing History:
Years Active: 2013-2014
Title: John Danilewicz: Innovator in Pharmaceutical Compositions
Introduction
John Danilewicz is a notable inventor based in Canterbury, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienopyrimidine compounds. With a total of 4 patents to his name, Danilewicz has established himself as a key figure in the development of therapeutic compositions.
Latest Patents
Danilewicz's latest patents include groundbreaking inventions such as "Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions." This invention relates to novel thienopyrimidine compounds that have therapeutic uses for the prophylaxis and treatment of diseases influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2. Another significant patent is "Cycloalkyl containing thienopyrimidines for pharmaceutical compositions," which similarly focuses on the therapeutic applications of thienopyrimidine compounds.
Career Highlights
Throughout his career, Danilewicz has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Evotec International GmbH. His work has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Danilewicz has collaborated with notable professionals in his field, including Phillip Black and Wesley Peter Blackaby. These collaborations have further enhanced his research and development efforts.
Conclusion
John Danilewicz is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact on the industry. His innovative patents and collaborations reflect his commitment to advancing medical science.